Severe iron overload with a novel aminolevulinate synthase mutation and hepatitis C infection. A case report

Blood Cells, Molecules, and Diseases

Volumn 42, Issue 1, 2009, Pages 1-4

  Lee, Pauline ^a   Rice, Lawrence ^b   McCarthy, John J ^b   Beutler, Ernest ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

ALAS2; Hemochromatosis; Hepatitis C; Iron overload; Iron responsive element; Liver transplant

Indexed keywords

5 AMINOLEVULINATE SYNTHASE; AMINOLEVULINATE SYNTHASE 2; FERROPORTIN; HEMOJUVELIN; HEPCIDIN; HFE PROTEIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; ORAL ANTIDIABETIC AGENT; TRANSFERRIN RECEPTOR 2; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; GENE MUTATION; GENETIC ASSOCIATION; HEART CATHETERIZATION; HEART TRANSPLANTATION; HEMOCHROMATOSIS; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRON OVERLOAD; LIVER TRANSPLANTATION; MALE; PHLEBOTOMY; PRIORITY JOURNAL; TREATMENT OUTCOME;

5-AMINOLEVULINATE SYNTHETASE; HEART TRANSPLANTATION; HEMOCHROMATOSIS; HEPATITIS C, CHRONIC; HUMANS; IRON; IRON OVERLOAD; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MUTATION; RESPONSE ELEMENTS;

HEPATITIS C VIRUS;

EID: 57949084602     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2008.08.001     Document Type: Article

References (18)

1. May A., and Bishop D.F. The molecular biology and pyridoxine responsiveness of X-linked sideroblastic anaemia. Haematologica 83 (1998) 56-70
2. Bekri S., May A., Cotter P.D., et al. A promoter mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemia. Blood 102 (2003) 698-704
3. Cazzola M., May A., Bergamaschi G., et al. Absent phenotypic expression of X-linked sideroblastic anemia in one of two brothers with a novel ALAS2 mutation. Blood 100 (2002) 4236-4238
4. Cazzola M., May A., Bergamaschi G., et al. Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females. Blood 96 (2000) 4363-4365
5. Aivado M., Gattermann N., Rong A., et al. X-linked sideroblastic anemia associated with a novel ALAS2 mutation and unfortunate skewed X-chromosome inactivation patterns. Blood Cells Mol. Dis. 37 (2006) 40-45
6. Cox T.C., Bawden M.J., Martin A., and May B.K. Human erythroid 5-aminolevulinate synthase: promoter analysis and identification of an iron-responsive element in the mRNA. EMBO J. 10 (1991) 1891-1902
7. Cazzola M., Bergamaschi G., Tonon L., et al. Hereditary hyperferritinemia-cataract syndrome: relationship between phenotypes and specific mutations in the iron-responsive element of ferritin light-chain mRNA. Blood 90 (1997) 814-821
8. Kato J., Fujikawa K., Kanda M., et al. A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am. J. Hum. Genet. 69 (2001) 191-197
9. Mok H., Jelinek J., Pai S., et al. Disruption of ferroportin 1 regulation causes dynamic alterations in iron homeostasis and erythropoiesis in polycythaemia mice. Development 131 (2004) 1859-1868
10. Silva I.S., Perez R.M., Oliveira P.V., et al. Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study. J. Gastroenterol. Hepatol. 20 (2005) 243-248
11. Gattoni A., Parlato A., Vangieri B., et al. Role of hemochromatosis genes in chronic hepatitis C. Clin. Ter. 157 (2006) 61-68
12. Eisenbach C., Gehrke S.G., and Stremmel W. Iron, the HFE gene, and hepatitis C. Clin. Liver Dis. 8 (2004) 775-785
13. Lanzara C., Roetto A., Daraio F., et al. The spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. Blood 103 (2004) 4317-4321
14. Roetto A., Papanikolaou G., Politou M., et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat. Genet. 33 (2003) 21-22
15. Lee P.L., Halloran C., West C., and Beutler E. Mutation analysis of the transferrin receptor-2 gene in patients with iron overload. Blood Cells Mol. Dis. 27 (2001) 285-289
16. Lee P.L., Beutler E., Rao S.V., and Barton J.C. Genetic abnormalities and juvenile hemochromatosis mutations of the HJV gene encoding hemojuvelin. Blood 103 (2004) 4669-4671
17. Lee P.L., Gelbart T., West C., et al. A study of genes that may modulate the expression of hereditary hemochromatosis: Transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2,and hepcidin. Blood Cells Mol. Dis. 27 (2001) 783-802
18. Barton J.C., and Lee P.L. Disparate phenotypic expression of ALAS2 R452H (nt 1407 G ->A) in two brothers, one with severe sideroblastic anemia and iron overload, hepatic cirrhosis, and hepatocellular carcinoma. Blood Cells Mol. Dis. 36 (2006) 342-346